Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Brown and Zoda take on key therapeutic business units
August 25, 2015
By: Kristin Brooks
Managing Editor, Contract Pharma
Bekki Brown and Tom Zoda, Ph.D., have been appointed to executive vice president, Clinical Development, General Medicine at INC Research, and executive vice president, Clinical Development, Central Nervous System (CNS), respectively, responsible for providing executive leadership for two of the company’s therapeutic business units. “Having built our organization around our therapeutic depth, we are delighted to appoint Bekki and Tom to further expand our therapeutic offerings in these important and fast-growing market segments,” said Michael Gibertini, PhD, President, Clinical Development. “INC is focused on providing specialized teams and experts in particular disciplines that fully understand each therapy area and how to best address customers’ needs. By structuring teams in this way, we are able to deliver unique insights that provide a clear advantage in accelerating new therapies to market for the benefit of patients in need.” Ms. Brown joined the company in 2001, and provides global leadership for the company’s General Medicine business unit, which specializes in clinical trials in areas ranging from infectious disease, respiratory disease, immunology and inflammation, gastrointestinal diseases, urology and women’s health. Since 2010, she has led operations and guided the group to its highest-ever level of performance. Dr. Zoda has worked in the pharmaceutical and CRO industry for more than 20 years, and has extensive experience designing, managing and overseeing clinical trials for the development of CNS therapeutics. He takes over the CNS unit from Dr. Gibertini, who now focuses on driving innovation and leveraging efficiencies across all of INC’s therapeutic business units. Since joining the company in 2009, he has directed large multi-center global trials focused on psychiatric and neurologic indications in areas such as schizophrenia, Alzheimer’s Disease, depression, anxiety, multiple sclerosis and epilepsy.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !